​

Voyager Therapeutics Ownership | Who Owns Voyager Therapeutics?


OverviewForecastRevenueFinancialsChart

Voyager Therapeutics Ownership Summary


Voyager Therapeutics is owned by 58.15% institutional investors, 14.84% insiders, and 27.01% retail investors. Blackrock funding, inc. /de is the largest institutional shareholder, holding 11.18% of VYGR shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.10% of its assets in Voyager Therapeutics shares.

VYGR Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockVoyager Therapeutics58.15%14.84%27.01%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock funding, inc. /de6.77M11.18%$18.15M
Blackrock5.31M9.30%$42.02M
Armistice capital3.50M5.96%$13.51M
Millennium management3.43M5.84%$13.23M
Vanguard group3.27M5.55%$12.84M
Vestal point capital, lp3.00M5.12%$11.59M
Vanguard capital management2.35M3.87%$6.29M
Geode capital management1.21M2.00%$3.25M
Opaleye management1.15M1.96%$4.44M
State street1.10M1.81%$2.94M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Opaleye management1.15M0.58%$4.44M
Birchview capital, lp224.92K0.35%$602.78K
Vestal point capital, lp3.00M0.32%$11.59M
Sphera funds management469.76K0.29%$1.81M
Diadema partners lp423.64K0.28%$1.64M
Armistice capital3.50M0.24%$13.51M
Clarivest asset management102.82K0.08%$813.32K
Virtus fund advisers4.03K0.07%$22.85K
Privium fund management b.v.120.00K0.06%$321.60K
Patriot financial group insurance agency205.73K0.04%$794.13K

Top Buyers

HolderShares% AssetsChange
Blackrock funding, inc. /de6.77M0.00%1.60M
Millennium management3.43M0.01%1.55M
Vestal point capital, lp3.00M0.32%1.53M
Blackrock5.31M0.00%915.17K
Mackenzie financial487.81K0.00%487.81K

Top Sellers

HolderShares% AssetsChange
Ecor1 capital---4.00M
Farallon capital management---715.00K
Erste asset management gmbh---638.90K
Great point partners---626.27K
Armistice capital3.50M0.24%-500.00K

New Positions

HolderShares% AssetsChangeValue
Mackenzie financial487.81K0.00%487.81K$1.31M
Diadema partners lp423.64K0.28%423.64K$1.64M
D. e. shaw98.72K0.00%98.72K$381.04K
Susquehanna portfolio strategies89.71K0.01%89.71K$346.30K
Empowered funds74.06K0.00%74.06K$198.48K

Sold Out

HolderChange
Nelson, van denburg & campbell wealth management group-6.00
Capital performance advisors llp-16.00
Mai capital management-29.00
Richards, merrill & peterson-30.00
Lindbrook capital-75.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261443.60%35,208,2005.04%581.83%809.59%34-8.11%
Mar 31, 202655-56.35%6,590,568-80.47%110.34%27-43.75%13-71.11%
Dec 31, 202578-34.45%16,989,289-43.76%281.09%30-43.40%29-25.64%
Sep 30, 2025111-0.89%25,893,441-21.95%441.38%472.17%375.71%
Jun 30, 2025109-6.03%33,129,2617.64%562.03%45-2.17%33-21.43%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF1.71M3.10%-
Vanguard Total Stock Mkt Idx Inv1.67M2.77%-
Vanguard Morn Total Stk Mkt Idx Investor1.67M2.77%-
Vanguard MStar Total Stk Mkt Idx Invest1.67M2.71%-
iShares Russell 2000 ETF1.35M2.16%-
Vanguard Institutional Extnd Mkt Idx Tr613.13K0.99%-
Fidelity Small Cap Index573.76K0.92%3.33K
iShares Russell 2000 Value ETF489.62K0.79%-
Vanguard Explorer Inv457.06K0.74%-
Russell 2000 Equity Index Fund B393.73K0.65%112.26K

Recent Insider Transactions


DateNameRoleActivityValue
Apr 02, 2026Sandrock Alfred President and CEOSell$44.55K
Feb 24, 2026Swartz Robin COO & CBOSell$24.35K
Feb 24, 2026Sandrock Alfred President and CEOSell$53.81K
Feb 24, 2026Jorgensen Nathan D. Chief Financial OfficerSell$17.60K
Feb 24, 2026Carter Todd Alfred Chief Scientific OfficerSell$15.69K

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q2-1
2026 Q1-10
2025 Q4-1
2025 Q3-1

VYGR Ownership FAQ


Who Owns Voyager Therapeutics?

Voyager Therapeutics shareholders are primarily institutional investors at 58.15%, followed by 14.84% insiders and 27.01% retail investors. The average institutional ownership in Voyager Therapeutics's industry, Biotech Stocks , is 385.89%, which Voyager Therapeutics falls below.

Who owns the most shares of Voyager Therapeutics?

Voyager Therapeutics’s largest shareholders are Blackrock funding, inc. /de (6.77M shares, 11.18%), Blackrock (5.31M shares, 9.30%), and Armistice capital (3.5M shares, 5.96%). Together, they hold 26.45% of Voyager Therapeutics’s total shares outstanding.

Does Blackrock own Voyager Therapeutics?

Yes, BlackRock owns 9.30% of Voyager Therapeutics, totaling 5.31M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 42.02M$. In the last quarter, BlackRock increased its holdings by 915.17K shares, a 20.81% change.

Who is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested?

Opaleye management is Voyager Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.58% of its assets in 1.15M Voyager Therapeutics shares, valued at 4.44M$.

Who is the top mutual fund holder of Voyager Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Voyager Therapeutics shares, with 3.10% of its total shares outstanding invested in 1.71M Voyager Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools